- Home
- SVII vs ECOR Comparison
SVII vs ECOR Comparison
Compare SVII & ECOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SVII
- ECOR
- Stock Information
- Founded
- SVII 2021
- ECOR 2005
- Country
- SVII United States
- ECOR United States
- Employees
- SVII N/A
- ECOR N/A
- Industry
- SVII Blank Checks
- ECOR Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- SVII Finance
- ECOR Health Care
- Exchange
- SVII Nasdaq
- ECOR Nasdaq
- Market Cap
- SVII 112.9M
- ECOR 110.4M
- IPO Year
- SVII 2022
- ECOR 2018
- Fundamental
- Price
- SVII $11.45
- ECOR $13.18
- Analyst Decision
- SVII
- ECOR Strong Buy
- Analyst Count
- SVII 0
- ECOR 1
- Target Price
- SVII N/A
- ECOR $25.00
- AVG Volume (30 Days)
- SVII 3.0K
- ECOR 156.6K
- Earning Date
- SVII 01-01-0001
- ECOR 05-07-2025
- Dividend Yield
- SVII N/A
- ECOR N/A
- EPS Growth
- SVII 13.16
- ECOR N/A
- EPS
- SVII 0.36
- ECOR N/A
- Revenue
- SVII N/A
- ECOR $23,327,000.00
- Revenue This Year
- SVII N/A
- ECOR $59.81
- Revenue Next Year
- SVII N/A
- ECOR $38.49
- P/E Ratio
- SVII $31.75
- ECOR N/A
- Revenue Growth
- SVII N/A
- ECOR 74.10
- 52 Week Low
- SVII $10.92
- ECOR $5.32
- 52 Week High
- SVII $11.70
- ECOR $19.49
- Technical
- Relative Strength Index (RSI)
- SVII 89.72
- ECOR 33.95
- Support Level
- SVII $11.20
- ECOR $12.51
- Resistance Level
- SVII $11.45
- ECOR $15.68
- Average True Range (ATR)
- SVII 0.01
- ECOR 1.46
- MACD
- SVII 0.01
- ECOR -0.41
- Stochastic Oscillator
- SVII 100.00
- ECOR 9.60
About SVII Spring Valley Acquisition Corp. II
Spring Valley Acquisition Corp II is a blank check company.
About ECOR electroCore Inc.
electroCore Inc is a commercial stage bioelectronic medicine company with a platform for non-invasive vagus nerve stimulation therapy initially focused on neurology. The company's product gammaCore is Food and Drug Administration cleared in the United States for adjunctive use for the preventive treatment of cluster headache in adult patients, the acute treatment of pain associated with episodic cluster headache in adult patients, the acute treatment of pain associated with migraine headache in adult patients and the prevention of migraine in adult patients, The use of gammaCore by adolescent patients and Treatment of hemicrania continua and paroxysmal hemicrania in adult patients.